- Cao, Shu-Qin
- Jiménez-Loygorri, Juan Ignacio
- Qiu, Yunguang
- Kang, You Jung
- Do, Khanh Van
- Smith, Annabel E.
- Huang, Junjie
- Pan, Jun-ping
- Mao, Lipeng
- Li, Ang
- Yang, Hangge
- Aman, Yahyah
- Lagartos, Maria Jose Donate
- Lautrup, Sofie Hindkjær
- Chen, Anbin
- Liang, Kristina Xiao
- Zhang, Hailong
- Yi, Juan
- Jin, Xurui
- Cheung, Tin Cho
- Apokotou, Olympia
- Papastefanaki, Florentia
- Matsas, Rebecca
- McEwan, William A
- Cheng, Feixiong
- Cho, Hansang
- Chen, Guobing
- Su, Huanxing
- Palikaras, Konstantinos
- Luo, Oscar Junhong
- Zhao, Qian Hua
- Ding, Ding
- van Duijn, Cornelia
- Tavernarakis, Nektarios
- Boya, Patricia
- Tencomnao, Tewin
- Fang, Evandro F
High consumption of colorful fruits and vegetables correlates with low dementia risk, but the exact molecules and the underlying biological mechanisms governing their bioactive profiles are largely unknown. Using a 10-year observational cohort study coupled with an AI-driven systems pharmacology platform, we identified a natural triterpenoid compound found in colorful fruits and vegetables, α-Amyrin (αA), as a therapeutic candidate for Alzheimer's disease (AD). The efficacy of αA in treating the symptoms of AD, such as Tau tangles, damaged mitochondria, and memory loss, was examined using cross-species models; αA retained memory in AD-like animal models while also strongly inhibiting Tau pathology, especially p-Tau217, in a cellular ‘Tau seeding’ system and in Tau[P301S] mice, followed by validation using a human 3D microfluidic system. At molecular level, αA is a robust mitochondrial regulator, enhancing mitochondrial stress resilience and activation of mitophagy. Mechanistically, αA inhibits dual leucine zipper kinase (DLK), leading to the inhibition of DLK-Sterile Alpha and TIR Motif Containing 1 (SARM1)-dependent neurodegeneration; this inhibition frees unc-51 Like Autophagy Activating Kinase 1 (ULK1) from the ULK1-SARM1 complex, allowing it to participate in autophagy/mitophagy. αA also shows strong translational potential with a 10.1 h half-life and the ability to cross the blood-brain barrier. Our results indicate that αA may act as a mitochondrial guardian against AD via modulating the DLK-SARM1-ULK1-autophagy/mitophagy axis while further preclinical and clinical studies are warranted, The authors confirm this project was funded by the Molecule
AG/VITADAO (#282942), the Research Council of Norway (#262175
and #334361), HELSE SØR-ØST (#2020001, #2021021, and #2023093),
NordForsk Foundation (#119986), the National Natural Science
Foundation of China (#81971327), Akershus University Hospital
(#269901, #261973, and #262960), the Civitan Norges Forskningsfond
for Alzheimers sykdom (#281931), the Czech Republic-Norway KAPPA
programme (with Martin Vyhnálek, #TO01000215), HORIZON-TMA-
MSCA-DN (#101073251, with Riekelt Houtkooper), and Wellcome Leap’s Dynamic Resilience Program (jointly funded by Temasek Trust)
(#104617). S.Q.C. is supported by Nasjonalforeningen for folkehelsen
(#43622), the scholarships from the Graduate School, Chulalongkorn
University to commemorate 72nd Anniversary of his Majesty King
Bhumibol Adulyadej and the 100th Anniversary Chulalongkorn
University Fund for Doctoral Scholarship as well as the 90th Anniversary
Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment
Fund) and Overseas Research Experience scholarship for Graduate
students. J. I. J.-L. is supported by an FPI fellowship from MCIN
(PRE2019-088222). G.C. is supported by Guangdong Basic and Applied
Basic Research Foundation (2022B1515120043). J.P.P is funded by
the Natural Science Foundation of China (grant no. 82301422). K.P.
is supported by grants from the Fondation Santé (19656) and the
European Research Council (GA 101077374 – SynaptoMitophagy).
N.T. is supported by the European Research Council, under the grant
agreement ERC-GA695190-MANNA. H.C. and K.V.D are supported
by the National Research Foundation (NRF-2020R1A2C2010285 and
NRF-I21SS7606036), the Ministry of Health & Welfare and Ministry of
Science and ICT (HU22C0115). R.M is funded by the Hellenic Fundation
for Research and Innovation grant HFRI-1019 DiseasePhenoTarget.
Y.J.K. is supported by NRF-2022R1I1A1A01063094. Q.H.Z. is supported
by National Natural Science Foundation of China (# 82371429), D.D.
is supported by the National Natural Science Foundation of China
(#82473701 and #82173599). Research in P.B. lab is supported by grant
PID2021-126864NB-I00 from MCIN, Spain, the University of of Fribourg and grant 310030-215271 from the SNSF, Switzerland., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Mamíferos - Roedores, in vitro - Tipos celulares - líneas estables humanas